BDBM352423 N-((1S*,4S*,7R*)-2-(3-Aminoisoxazolo[5,4-c]pyridin-7-yl)-2-azabicyclo[2.2.1]heptan-7-yl)-2-chloro-4-(3-methyl-1H-1,2,4-triazol-1-yl)benzamide::US9808445, 2
SMILES: Cc1ncn(n1)-c1ccc(C(=O)NC2C3CCC2N(C3)c2nccc3c(N)noc23)c(Cl)c1
InChI Key: InChIKey=WBDHYAPOACOYPF-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Coagulation factor IX (Homo sapiens (Human)) | BDBM352423 (N-((1S*,4S*,7R*)-2-(3-Aminoisoxazolo[5,4-c]pyridin...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp.; Mochida Pharmaceutical Co., Ltd. US Patent | Assay Description Inhibitory activity against factor IXa was tested using the substrate SPECTROFLUOR FIXa (american diagnostica inc.; 500 West Avenue, Stamford, Conn. ... | US Patent US9808445 (2017) BindingDB Entry DOI: 10.7270/Q28G8NV1 | |||||||||||
More data for this Ligand-Target Pair |